Table 1: Clinical characteristics of the patients.

Case 1Case 2Case 3Case 4Case 5

Age at kidney transplantation (years)4124383327
Age at onset of FSGS (years)4011322617
Gender (male/female)FemaleMaleFemaleMaleFemale
Donor relationshipMotherMotherMotherMotherMother
Dialysis duration (months)229000
Preoperative anti-HLA donor antibodyNegativeNegativeNegativeNegativeNegative
Preoperative dose of rituximab (mg)100100100100100
Preoperative PE sessions (number)20000
Preoperative LDL apheresis sessions (number)12222
Postoperative observation period (months)22191432

FSGS, focal segmental glomerulosclerosis; HLA, human leukocyte antigen; PE, plasma exchange; LDL, low-density lipoprotein.